Could cause temporary or reversible harm; serious harm is unlikely.
Lack of Assurance of Sterility: Powder discoloration due to small crack in some vials.
| Brand name | PANTOPRAZOLE SODIUM |
| Generic name | PANTOPRAZOLE SODIUM |
| Active ingredient(s) | PANTOPRAZOLE SODIUM |
| Distributed by / for | BE Pharmaceuticals Inc. 203 New Edition Court Cary, NC 27511 |
| NDC | 71839-122-01 |
| Full product label | Pantoprazole Sodium for Injection 40mg per vial, Single dose vials NDC 71839-122-01 Packaged as (a) 10 Single-dose vials, NDC 71839-122-10; (b) 25 Single-dose vials, NDC 71839-122-25; Rx Only, Mfd. in India for and Distributed by: BE Pharmaceuticals Inc. 203 New Edition Court Cary, NC 27511. |
| Recalling firm | BE PHARMACEUTICALS AG |
| Distribution | Nationwide in the USA |
| Quantity | 41,148 vials |
| Recall initiated | 2023-09-05 |
| Report date | 2023-09-20 |
| Recall completed | 2025-04-08 |
| Recall number | D-1148-2023 |
| Classification | Class II |
| FDA status | Terminated |
| Origin on file | Zug Switzerland |
Source: U.S. FDA enforcement database (openFDA). Look this up on the official FDA recalls site ↗